KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Accounts Payables (2017 - 2025)

Historic Accounts Payables for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $3.6 million.

  • Cardlytics' Accounts Payables fell 799.59% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 799.59%. This contributed to the annual value of $3.7 million for FY2024, which is 1663.28% down from last year.
  • Latest data reveals that Cardlytics reported Accounts Payables of $3.6 million as of Q3 2025, which was down 799.59% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Cardlytics' Accounts Payables peaked at $5.2 million during Q2 2021, and registered a low of $1.7 million during Q2 2023.
  • Its 5-year average for Accounts Payables is $3.7 million, with a median of $3.8 million in 2021.
  • As far as peak fluctuations go, Cardlytics' Accounts Payables skyrocketed by 34324.55% in 2021, and later plummeted by 6002.88% in 2025.
  • Over the past 5 years, Cardlytics' Accounts Payables (Quarter) stood at $4.6 million in 2021, then decreased by 18.49% to $3.8 million in 2022, then increased by 17.53% to $4.4 million in 2023, then dropped by 16.63% to $3.7 million in 2024, then dropped by 2.06% to $3.6 million in 2025.
  • Its Accounts Payables stands at $3.6 million for Q3 2025, versus $1.9 million for Q2 2025 and $4.4 million for Q1 2025.